Ixekizumab
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 0095/2023-SML | 25. 01. 2023 | ELI LILLY ČR, s.r.o. | 6 085 508,66 | 5 532 280,60 | 6 085 508,66 | 5 532 280,60 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Písemná zpráva zadavatele_Ixekizumab_EP.pdf | Písemná zpráva zadavatele | 27. 01. 2023 06:58 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| ELI LILLY ČR, s.r.o. | Praha | 6 085 508,66 | 5 532 280,60 | CZK |
Price Actually Paid in Each Year of Performance
| 0095/2023-SML | 2023 | 1 825 652,64 | 1 659 684,18 |